MétaCan
Menu
Back to cohort
Record W2045148891 · doi:10.1038/clpt.2011.10

The Value and Benefits of the International Conference on Harmonisation to Drug Regulatory Authorities: Advancing Harmonization for Better Public Health

2011· article· en· W2045148891 on OpenAlexaff
J A Molzon, A Giaquinto, Lars Lindström, Toshiyoshi Tominaga, Mike Ward, Petra Doerr, Lester Callaway Hunt, Lembit Rägo

Bibliographic record

VenueClinical Pharmacology & Therapeutics · 2011
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicPharmaceutical Economics and Policy
Canadian institutionsHealth Canada
Fundersnot available
KeywordsHarmonizationPublic healthDrug approvalDrugValue (mathematics)BusinessPharmacologyMedicineEnvironmental healthPublic administrationPolitical scienceComputer science

Abstract

fetched live from OpenAlex

The International Conference on Harmonisation (ICH) is an unparalleled undertaking, which has brought together drug regulatory authorities and pharmaceutical trade associations from Europe, Japan, and the United States, to discuss the scientific and technical aspects of medical product registration. Launched in 1990, the value and benefits of ICH to regulators are being realized. ICH has harmonized submission requirements and created a harmonized submission format that is relieving both companies and regulatory authorities of the burdens of assembling and reviewing separate submissions for each region. As more countries embrace ICH guidelines, we anticipate additional benefits, including the promotion of good review practices and, ultimately, a common regulatory language that will facilitate further interactions among global drug regulatory authorities.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.345
metaresearch head score (Gemma)0.520
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.345
Threshold uncertainty score0.807

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.3450.520
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0070.008
Science and technology studies0.0060.020
Scholarly communication0.0290.026
Open science0.0050.016
Research integrity0.0210.025
Insufficient payload (model declined to judge)0.0140.006

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.358
GPT teacher head0.405
Teacher spread0.046 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations55
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueClinical Pharmacology & TherapeuticsSame topicPharmaceutical Economics and PolicyFrench-language works237,207